Furthermore, others have shown that activation of FAK signaling is associated with EGFR-TKI resistance in NSCLC [52], although this is currently not of great importance for squamous cell carcinoma of the lung. The gene discussed is PTK2; the disease is non-small cell lung carcinoma.